The pentose phosphate pathway, also known as the "Phosphogluconate pathway" or the "Hexose monophosphate shunt/pathway," occurs in the cytosol and involves the oxidation of glucose-6-phosphate to produce NADPH, crucial for biosynthesis in animals
The oxidative phase of the pentose phosphate pathway converts glucose-6-P to ribulose-5-P, producing 2 NADPH and 1 CO2, while the non-oxidative phase involves converting 6 molecules of ribulose-5-P into 4 molecules of F6P and 2 molecules of GAP using carbon shuffle reactions
The flux through the pentose phosphate pathway is controlled depending on [ATP], [NADPH], and nucleotide demand
G6PDH deficiency can lead to cellular damage due to oxidative stress, causing lipid peroxidation, breakdown of cell components, and susceptibility of red blood cells; favism from fava beans can exacerbate symptoms
G6PDH deficiency provides resistance to malaria as the malaria parasite is sensitive to oxidative stress, and the increased oxidative stress in red blood cells of G6PDH-deficient individuals negatively impacts the parasite